Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Immunostimulant

DRUG CLASS:

Immunostimulant

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

astuprotimut-R (0)

tirvalimogene teraplasmid (2)

Histone H3.3-K27M Neoantigen Vaccine Therapy (1)

sipuleucel-T (1)

Versamune HPV (1)

aDC1 vaccine (0)

Ad-CCL21-DC (0)

AdHER2/neu DC Vaccine (0)

allogeneic K562-GM tumor cell vaccine (0)

allogeneic Myeloma GM-CSF Vaccine (0)

bioengineered allogeneic immune cells (0)

velimogene aliplasmid (0)

alpha-lactalbumin vaccine (0)

APVAC1 vaccine (0)

autologous Tcm cellular immunotherapy (0)

BCG vaccine (0)

interferon alpha 2b (0)

dasiprotimut-T (0)

BN-Brachyury (0)

CD25hi Treg depleted DLI (0)

Escherichia coli (0)

recombinant human papillomavirus bivalent vaccine (0)

dendritic cell vaccine (0)

cancer vaccine MUC-1 (0)

DC-AdGMCAIX (0)

autologous dendritic cell vaccine leaded with autologous tumor cell lysate (0)

Dendritic cell renal cell carcinoma fusion vaccine (0)

DNAJB1-PRKACA peptide vaccine (0)

EP-101 STEMVAC (0)

FR Alpha Peptide Vaccine (0)

Fusion-VAC-XS15 (0)

human papillomavirus 9-valent vaccine, recombinant (0)

types 6, 11, 16, 18 (0)

gp96-Ig vaccine (0)

GSK2130579A (0)

GSK2302032A (0)

GVAX leukemia vaccine (0)

GVAX lung cancer vaccine (0)

H1299 cell lysate with iscomatrix adjuvant vaccine (0)

H1299 lung cancer cell lysate vaccine with Montanide ISA-51 VG adjuvant (0)

HER2- and HER3-primed dendritic cells (0)

HER-2 pulsed DC1 (0)

HRXG-K-1939 (0)

IDH1R132H peptide vaccine (0)

autologous γδ T lymphocytes (0)

iNeo-Vac-P01 (0)

iNeo-Vac-R01 (0)

KRAS peptide vaccine (0)

axalimogene filolisbac (0)

mammaglobin-A DNA vaccine (0)

autologous dendritic cell vaccine (0)

multi-epitope melanoma peptide (0)

MVA-BN-Brachyury IV vaccine (0)

neoantigen DNA vaccine (0)

neoantigen peptide vaccine (0)

NEO_PLIN2101 (0)

nonavalent HPV vaccine (0)

NUMARZU-001 (0)

NY-ESO-1 combined with MPLA vaccine (0)

NY-ESO-1 Iscomatrix (0)

ruxotemitide (0)

oral therapeutic vaccine V3-X (0)

p.DOM-WT1-126 DNA vaccine (0)

PEG IFN-a 2b (0)

PF-06753512 (0)

PF-07263689 (0)

pING-hHER3FL (0)

PNV21 vaccine (0)

Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine (0)

PolyPEPI 1018 (0)

polyvalent vaccine-KLH conjugate (0)

rilimogene galvacirepvec (0)

HSP Gp96 vaccine (0)

RNA-NP vaccine (0)

self-amplifying RNA cancer vaccine (0)

BCG vaccine (0)

SQZ-PBMC-HPV (0)

EGFREDVmiR-16 (0)

TG01 vaccine (0)

live attenuated bacillus Calmette-Guerin (0)

CMV-MVA vaccine (0)

TVI-Brain-1 (0)

Undisclosed ovarian cancer vaccine (0)

Undisclosed VLP vaccine (0)

alpha-tocopheroloxyacetic acid (0)

VV-GMCSF-Lact (0)

astuprotimut-R (0)

›

No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	sipuleucel-T Sensitive: A2 - Guideline sipuleucel-T Sensitive : A2	sipuleucel-T Sensitive: A2 - Guideline sipuleucel-T Sensitive : A2
No biomarker	Glioblastoma	No biomarker	Glioblastoma	DNX-2401 Sensitive: B - Late Trials DNX-2401 Sensitive : B	DNX-2401 Sensitive: B - Late Trials DNX-2401 Sensitive : B
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	RV001 Sensitive: B - Late Trials RV001 Sensitive : B	RV001 Sensitive: B - Late Trials RV001 Sensitive : B
No biomarker	Melanoma	No biomarker	Melanoma	PVS-RIPO Sensitive: B - Late Trials PVS-RIPO Sensitive : B	PVS-RIPO Sensitive: B - Late Trials PVS-RIPO Sensitive : B
No biomarker	Glioblastoma	No biomarker	Glioblastoma	VBI-1901 Sensitive: B - Late Trials VBI-1901 Sensitive : B	VBI-1901 Sensitive: B - Late Trials VBI-1901 Sensitive : B
HLA-A2 positive	Non Small Cell Lung Cancer	HLA-A2 positive	Non Small Cell Lung Cancer	OSE 2101 Sensitive: B - Late Trials OSE 2101 Sensitive : B	OSE 2101 Sensitive: B - Late Trials OSE 2101 Sensitive : B
No biomarker	Melanoma	No biomarker	Melanoma	BNT111 Sensitive: B - Late Trials BNT111 Sensitive : B	BNT111 Sensitive: B - Late Trials BNT111 Sensitive : B
No biomarker	Breast Cancer	No biomarker	Breast Cancer	SV-BR-1-GM Sensitive: B - Late Trials SV-BR-1-GM Sensitive : B	SV-BR-1-GM Sensitive: B - Late Trials SV-BR-1-GM Sensitive : B
No biomarker	Head and Neck Cancer	No biomarker	Head and Neck Cancer	pembrolizumab + Versamune HPV Sensitive: B - Late Trials pembrolizumab + Versamune HPV Sensitive : B	pembrolizumab + Versamune HPV Sensitive: B - Late Trials pembrolizumab + Versamune HPV Sensitive : B
No biomarker	Glioblastoma	No biomarker	Glioblastoma	ERC1671 Sensitive: B - Late Trials ERC1671 Sensitive : B	ERC1671 Sensitive: B - Late Trials ERC1671 Sensitive : B
No biomarker	Merkel Cell Carcinoma	No biomarker	Merkel Cell Carcinoma	ITI-3000 Sensitive: B - Late Trials ITI-3000 Sensitive : B	ITI-3000 Sensitive: B - Late Trials ITI-3000 Sensitive : B
EGFR negative + ALK negative	Non Small Cell Lung Cancer	EGFR negative + ALK negative	Non Small Cell Lung Cancer	OSE 2101 Sensitive: B - Late Trials OSE 2101 Sensitive : B	OSE 2101 Sensitive: B - Late Trials OSE 2101 Sensitive : B